Skip to content

Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics

Bacterial Infections in Patients with Cirrhosis in Argentina

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03919032
Enrollment
472
Registered
2019-04-18
Start date
2018-10-16
Completion date
2019-12-31
Last updated
2025-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Infections, Cirrhosis, Morality, Resistant Infection

Brief summary

In recent years, there has been an increasing prevalence of bacterial infections caused by multiresistant and extremely resistant organisms in patients with cirrhosis. These infections are associated with a worse prognosis, generate difficulties in the management of the patient during hospitalization and increase health costs. The main objective of this project is to estimate the prevalence of infections by multiresistant bacteria in patients with cirrhosis. Additionally, the prevalence of other antibiotic resistance patterns and morbi-mortality in the study population will be evaluated. For these purposes, a multicenter prospective cohort study will be carried out, including patients with cirrhosis who present bacterial infections at the time of admission, or during hospitalization. Performing a study in Argentina on the clinical and microbiological characteristics of bacterial infections in patients with cirrhosis could be very useful to develop new strategies for prevention and treatment of this severe complication.

Interventions

This is an observational study without intervention

Sponsors

Hospital Italiano de Buenos Aires
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with cirrhosis * Patients older than 17 years. * Patients who are hospitalized for bacterial infections, or who develop bacterial infections while hospitalized

Exclusion criteria

• Refusal to participate in the informed consent process

Design outcomes

Primary

MeasureTime frame
To estimate the prevalence of infections caused by multi-resistant microorganisms in patients with cirrhosisat the moment of the diagnosis of the bacerial infection

Secondary

MeasureTime frame
To evaluate variables associated with infections caused by multi-resistant microorganisms in patients with cirrhosisat the moment of the diagnosis of the bacerial infection
To evaluate the effect of infections caused by multi-resistant microorganisms on the in-hospital survival of patients with cirrhosis30 days

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026